Glooko
Glooko offers a hardware-agnostic diabetes management platform that syncs with various devices to provide reports and actionable analytics.
Secondary Market Price
How Glooko Measures Up
To help you manage your Glooko equity, Prospect has run the company through our machine learning model.
Prospect Rating
This rating reflects our belief in this company's potential to grow to that many times its current value in 4 years. For an employee with stock, this rating suggests a potential return on equity, but it also comes with some risk.
Exit Risk
--
Our rating is a reflection of the likelihood of this company achieving a liquidity event for its employees based on the quality of investors, funding stage, founders, and more.
Funding Stage
Series F
A company’s funding stage reflects how established it is, how quickly it is scaling, and the average impact an employee may have when joining.
Secondary Market Price Chart
Create a free account to unlock real-time secondary market prices and future projections of Glooko's value.
Sign up to Unlock the Latest DataData will be available soon.
Sign up to receive notifications when it is available.
Prospect Projected Future Glooko Prices
Prospect’s machine learning model has been trained on the same data top-tier investors use to project the likely range of outcomes for Glooko's equity. Create a free account to view 10th-90th percentile projections over 2, 4, and 6 years.
Powerful tools to earn more from your equity
Company Description
Glooko provides a connected care platform for diabetes management used by healthcare providers and patients. The company's system is cloud-based and hardware-agnostic, integrating with electronic health records (EHRs), diabetes devices such as continuous glucose monitors (CGMs) and smart pens, and health monitoring applications. This integration allows for the consolidation of patient data to provide analytics and insights for care teams and individuals. The platform is used by more than 4.4 million people and in 8,000 clinics across 30 countries. Founded in 2010, Glooko was established to streamline diabetes management by unifying data from various sources to support clinical workflows and patient engagement.
The company continues to develop its offerings, with recent updates including a new clinic dashboard for care teams, a redesigned food tracker in its mobile app, and the introduction of the Glycemia Risk Index (GRI) in its 2025 Global Diabetes Report. Glooko's CEO has discussed innovation plans for 2026 and beyond, supported by a Series F funding round of $100 million in November 2024. Recent announcements also highlight the platform's role in helping certified diabetes care and education specialists (CDCES) support patients in self-management programs.
- Georgian
- Health Catalyst Capital
- Canaan Partners
- Novo Nordisk
- Insulet
- Mayo Clinic
- Medtronic
- Samsung Venture Investment Corporation
- Social Capital
- Lifeforce Ventures
- The Social+Capital Partnership
- Cambrian Ventures
- Prospect Venture Partners
- Xtreme Labs
- Co-Founder, Yogen Dalal
- Co-Founder, Sundeep Madra
- Co-Founder, Chamath Palihapitiya
Peer Group Comparison
Vs Peer Group of >$4B Startups
Frequently Asked Questions
Joining Anduril as an employee is another way to acquire equity, typically through stock options included in compensation packages.
Is Glooko worth joining?
Deciding whether to join Glooko depends on your personal career goals and your assessment of the company's future. Tools like Prospect can help you evaluate the financial side of your offer by modeling the potential future value of your equity compensation.
What should I do with my Glooko stock?
Managing your Glooko stock requires a personalized strategy based on your financial goals and tax situation. Platforms like Prospect offer tools to help you create an optimized option exercise strategy and minimize your tax burden.
Can you sell Glooko stock?
Selling stock in a private company like Glooko is possible during specific events like tender offers or on secondary markets, but it isn't as simple as selling public stock. Prospect provides tools to navigate these opportunities and determine which shares are most tax-optimal to sell.
How can I find the value of my Glooko stock?
The official value of private stock is often based on a 409A valuation, but this doesn't reflect its potential future worth. You can get a better projection by using platforms like Prospect, which use predictive models to forecast your equity's future value.
What is Glooko's equity worth?
Glooko's total equity worth, or valuation, is private information that changes with events like new funding rounds. To understand how the company's valuation affects your personal equity's net worth, you can use financial modeling tools from services like Prospect.
What is Glooko's stock ticker symbol?
As a private company, Glooko does not have a stock ticker symbol because it is not listed on a public stock exchange. Ticker symbols are only assigned to companies once they undergo an Initial Public Offering (IPO).
Can I buy or sell Glooko stock?
For employees, "buying" Glooko stock usually means exercising your stock options, while selling is typically limited to specific events like tender offers. Equity management platforms like Prospect provide tools to help you optimize both exercising and selling decisions to maximize your financial outcome.
What is the criteria to buy or invest in Glooko stock?
The primary way to acquire Glooko stock is by being an employee who is granted equity compensation like stock options or RSUs. Otherwise, investment is generally limited to accredited investors participating in private financing rounds.
